Advertisement

Topics

ChemioCare plans IPO and raise funds to bring 'transformative' drug to the market

10:00 EDT 17 May 2018 | Proactive Investors

ChemioCare CEO Pedro Lichtinger tells Proactive Investors the biopharmaceutical company is focused on treating the side effects of chemotherapy.

Founded about a year ago, Lichtinger says the company's transdermal patch technology will help cancer patients going through chemotherapy to experience significantly less side effects of the drug including less nausea and vomiting.

Lichtinger says the company is planning to go public and list on the Nasdaq and the TSX in about 10 months, using the capital raised to run the clinical trials for the drug.

Original Article: ChemioCare plans IPO and raise funds to bring 'transformative' drug to the market

NEXT ARTICLE

More From BioPortfolio on "ChemioCare plans IPO and raise funds to bring 'transformative' drug to the market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...